In colon cancer, CEA levels have been shown to be an important prognostic factor in node-negative disease, with an increase of the preoperative serum CEA level associated with an increased risk of recurrence (Harrison et al., 1997). The gene discussed is CEACAM5; the disease is malignant colon neoplasm.